3-hydroxyflavone has been researched along with Astrocytosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinda, AK; Joshi, B; Reeta, KH; Sharma, U; Singh, D; Upadhyay, D; Wasan, H | 1 |
| Gopinath, K; Prakash, D; Sudhandiran, G | 1 |
2 other study(ies) available for 3-hydroxyflavone and Astrocytosis
| Article | Year |
|---|---|
Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex.
Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Flavonols; Gliosis; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury | 2022 |
Fisetin enhances behavioral performances and attenuates reactive gliosis and inflammation during aluminum chloride-induced neurotoxicity.
Topics: Aluminum Chloride; Aluminum Compounds; Animals; Antioxidants; Astrocytes; Ataxia; Behavior, Animal; Cerebral Cortex; Chlorides; Cytokines; Drug Evaluation, Preclinical; Exploratory Behavior; Flavonoids; Flavonols; Gliosis; Hippocampus; Lipid Peroxidation; Male; Memory Disorders; Mice; Microglia; Muscle Strength; Nerve Tissue Proteins; Neuroprotective Agents; Nitric Oxide Synthase Type II; Random Allocation; Recognition, Psychology | 2013 |